Search for the optimal treatment of ovarian cancer: heavy metals, "belly baths," and ... yew trees

Editorial

F Muggia. J Clin Oncol. 1992 May.

. 1992 May;10(5):683-5.

doi: 10.1200/JCO.1992.10.5.683.

No abstract available

Comment on

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.
Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, Surwit EA, Malvlya VK, Nahhas WA, Jolles CJ. Alberts DS, et al. J Clin Oncol. 1992 May;10(5):706-17. doi: 10.1200/JCO.1992.10.5.706. J Clin Oncol. 1992. PMID: 1569443 Clinical Trial.
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.
Swenerton K, Jeffrey J, Stuart G, Roy M, Krepart G, Carmichael J, Drouin P, Stanimir R, O'Connell G, MacLean G, et al. Swenerton K, et al. J Clin Oncol. 1992 May;10(5):718-26. doi: 10.1200/JCO.1992.10.5.718. J Clin Oncol. 1992. PMID: 1569444 Clinical Trial.
Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.
Rothenberg ML, Ozols RF, Glatstein E, Steinberg SM, Reed E, Young RC. Rothenberg ML, et al. J Clin Oncol. 1992 May;10(5):727-34. doi: 10.1200/JCO.1992.10.5.727. J Clin Oncol. 1992. PMID: 1569445 Clinical Trial.